The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Chwastiak, L.
* Articles by Kraft, G. H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Chwastiak, L.
* Articles by Kraft, G. H.
Related Collections
* Depression
* Other Neuropsychiatric Disorders
* Syndromes Secondary to General Medical Disorders
* Other Neuroscience
Am J Psychiatry 159:1862-1868, November 2002
© 2002 American Psychiatric Association


Article

Depressive Symptoms and Severity of Illness in Multiple Sclerosis: Epidemiologic Study of a Large Community Sample

Lydia Chwastiak, M.D., M.P.H., Dawn M. Ehde, Ph.D., Laura E. Gibbons, Ph.D., Mark Sullivan, M.D., Ph.D., James D. Bowen, M.D., and George H. Kraft, M.D.

OBJECTIVE: Previous research has shown high prevalence rates of depression in multiple sclerosis patients seen in specialty clinics. The relationships among depressive symptoms and severity, duration, and course of multiple sclerosis are controversial. METHOD: A survey was mailed to members of the Multiple Sclerosis Association of King County (Wash.). Of the 1,374 eligible participants, 739 returned the survey, a response rate of 53.8%. Data about demographic characteristics, employment, and duration and course of multiple sclerosis were collected. Severity of multiple sclerosis was determined by the Expanded Disability Status Scale, self-report version. Severity of depressive symptoms was evaluated with the Center for Epidemiologic Studies Depression Scale (CES-D Scale). Analysis of covariance was used to compare mean CES-D Scale scores across categories of multiple sclerosis, and logistic regression was used to identify variables associated with clinically significant depression. RESULTS: Clinically significant depressive symptoms (CES-D Scale score >=16) were found in 41.8% of the subjects, and 29.1% of the subjects had moderate to severe depression (score >=21). Subjects with advanced multiple sclerosis were much more likely to experience clinically significant depressive symptoms than subjects with minimal disease. Shorter duration of multiple sclerosis was associated with a greater likelihood of significant depressive symptoms, but the pattern of illness progression was not. CONCLUSIONS: In this large community sample, the severity of multiple sclerosis was more strongly associated with depressive symptoms than was pattern of illness. Clinicians should evaluate depression in patients with recent diagnoses of multiple sclerosis, major changes in functioning, or limited social support.




This article has been cited by other articles:


Home page
Mult SclerHome page
F. E Munschauer III, R. H. Benedict, C. V Granger, and P. M Niewczyk
Introduction to Best practice recommendations for the selection and management of patients with MS on natalizumab
Multiple Sclerosis, November 1, 2009; 15(4_suppl): S1 - S6.
[PDF]


Home page
Mult SclerHome page
S Kern, W Schrempf, H Schneider, T Schultheiss, H Reichmann, and T Ziemssen
Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis
Multiple Sclerosis, June 1, 2009; 15(6): 752 - 758.
[Abstract] [PDF]


Home page
Mult SclerHome page
K Lode, E Bru, G Klevan, K. Myhr, H Nyland, and J. Larsen
Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis
Multiple Sclerosis, May 1, 2009; 15(5): 638 - 643.
[Abstract] [PDF]


Home page
Mult SclerHome page
R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated
Multiple Sclerosis, March 1, 2009; 15(3): 385 - 392.
[Abstract] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
J. Seymour and T. B. Benning
Depression, cardiac mortality and all-cause mortality
Adv. Psychiatr. Treat., March 1, 2009; 15(2): 107 - 113.
[Abstract] [Full Text] [PDF]


Home page
Qual Health ResHome page
D. M. Kirkpatrick Pinson, A. J. Ottens, and T. A. Fisher
Women Coping Successfully With Multiple Sclerosis and the Precursors of Change
Qual Health Res, February 1, 2009; 19(2): 181 - 193.
[Abstract] [PDF]


Home page
Therapeutic Advances in Neurological DisordersHome page
I. S. Haussleiter, M. Brune, and G. Juckel
Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment
Therapeutic Advances in Neurological Disorders, January 1, 2009; 2(1): 13 - 29.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Hirst, R Swingler, D A S Compston, Y Ben-Shlomo, and N P Robertson
Survival and cause of death in multiple sclerosis: a prospective population-based study
J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1016 - 1021.
[Abstract] [Full Text] [PDF]


Home page
J Health PsycholHome page
K. I. Pakenham
Making Sense of Illness or Disability: The Nature of Sense Making in Multiple Sclerosis (MS)
J Health Psychol, January 1, 2008; 13(1): 93 - 105.
[Abstract] [PDF]


Home page
Mult SclerHome page
S. Kern and T. Ziemssen
Review: Brain immune communication psychoneuroimmunology of multiple sclerosis
Multiple Sclerosis, January 1, 2008; 14(1): 6 - 21.
[Abstract] [PDF]


Home page
Mult SclerHome page
K. Cetin, K.L. Johnson, D.M. Ehde, C.M. Kuehn, D. Amtmann, and G.H. Kraft
Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample
Multiple Sclerosis, September 1, 2007; 13(8): 1046 - 1053.
[Abstract] [PDF]


Home page
Mult SclerHome page
D C Mohr, S L Hart, L Julian, and E S Tasch
Screening for depression among patients with multiple sclerosis: two questions may be enough
Multiple Sclerosis, March 1, 2007; 13(2): 215 - 219.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K Gottberg, U Einarsson, S Fredrikson, L von Koch, and L W Holmqvist
A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence
J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 60 - 65.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J Porcel, J Rio, A Sanchez-Betancourt, M J Arevalo, M Tintore, N Tellez, C Borras, C Nos, and X Montalban
Long-term emotional state of multiple sclerosis patients treated with interferon beta
Multiple Sclerosis, November 1, 2006; 12(6): 802 - 807.
[Abstract] [PDF]


Home page
Mult SclerHome page
D M Ehde, T L Osborne, M A Hanley, M P Jensen, and G H Kraft
The scope and nature of pain in persons with multiple sclerosis
Multiple Sclerosis, September 1, 2006; 12(5): 629 - 638.
[Abstract] [PDF]


Home page
Adv. Psychiatr. Treat.Home page
K. Jefferies
The neuropsychiatry of multiple sclerosis
Adv. Psychiatr. Treat., May 1, 2006; 12(3): 214 - 220.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D C Mohr, S L Hart, I Fonareva, and E S Tasch
Treatment of depression for patients with multiple sclerosis in neurology clinics
Multiple Sclerosis, April 1, 2006; 12(2): 204 - 208.
[Abstract] [PDF]


Home page
NeurologyHome page
G. H. Kraft, J. Bowen, B. Stankoff, E. Waubant, C. Lubetzki, M. Clanet, for the French Modafinil Study Group, K. W. Rammohan, D. J. Lynn, B. Stankoff, et al.
Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
Neurology, December 27, 2005; 65(12): 1995 - 1997.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Bronnum-Hansen, E Stenager, E Nylev Stenager, and N Koch-Henriksen
Suicide among Danes with multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, October 1, 2005; 76(10): 1457 - 1459.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
Goldman Consensus Group
The Goldman Consensus statement on depression in multiple sclerosis
Multiple Sclerosis, June 1, 2005; 11(3): 328 - 337.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
R J Siegert and D A Abernethy
Depression in multiple sclerosis: a review
J. Neurol. Neurosurg. Psychiatry, April 1, 2005; 76(4): 469 - 475.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. J Randolph and P. A Arnett
Depression and fatigue in relapsing-remitting MS: the role of symptomatic variability
Multiple Sclerosis, April 1, 2005; 11(2): 186 - 190.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Rickards
Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke
J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(suppl_1): i48 - i52.
[Full Text] [PDF]


Home page
NeurologyHome page
R. M. Williams, A. P. Turner, M. Hatzakis Jr., J. D. Bowen, A. A. Rodriquez, and J. K. Haselkorn
Prevalence and correlates of depression among veterans with multiple sclerosis
Neurology, January 11, 2005; 64(1): 75 - 80.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
Z. BUTT and P. CRAWFORD
Illness Severity and Depression in Multiple Sclerosis
Am J Psychiatry, August 1, 2004; 161(8): 1504 - 1504.
[Full Text] [PDF]


Home page
Mult SclerHome page
D. M Ehde, L. E Gibbons, L. Chwastiak, C. H Bombardier, M. D Sullivan, and G. H Kraft
Chronic pain in a large community sample of persons with multiple sclerosis
Multiple Sclerosis, December 1, 2003; 9(6): 605 - 611.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
H Rickards
The outcome of depressive disorders in the setting of neurological illness.
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 842 - 843.
[Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org